Total Payments
$436.19
2024 Payments
$105.21
Companies
11
Transactions
29
Medicare Patients
2,312
Medicare Billing
$87,540
Payment Breakdown by Category
Food & Beverage$436.19 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $436.19 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $105.09 | 7 | $0 (2024) |
| Novo Nordisk Inc | $85.53 | 5 | $0 (2024) |
| Lilly USA, LLC | $67.43 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $61.11 | 4 | $0 (2023) |
| Corcept Therapeutics | $29.60 | 2 | $0 (2021) |
| Chiesi USA, Inc. | $19.23 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.35 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $14.78 | 1 | $0 (2023) |
| Biogen, Inc. | $13.98 | 1 | $0 (2024) |
| Abbott Laboratories | $11.66 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.21 | 6 | Novo Nordisk Inc ($37.54) |
| 2023 | $90.94 | 6 | Lilly USA, LLC ($26.40) |
| 2022 | $73.52 | 5 | Novo Nordisk Inc ($32.03) |
| 2021 | $166.52 | 12 | AbbVie Inc. ($72.67) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Neurology | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: ACROMEGALY | ||||||
| 02/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 11/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Gastroenterology | ||||||
| 03/20/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Neuroscience | ||||||
| 03/03/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INSOMNIA | ||||||
| 02/21/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Neuroscience | ||||||
| 01/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 10/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Neuroscience | ||||||
| 07/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Gastroenterology | ||||||
| 05/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 03/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes Care | ||||||
| 10/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Endocrinology | ||||||
| 07/22/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Endocrinology | ||||||
| 07/21/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Gastroenterology | ||||||
| 06/09/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 311 | 408 | $61,841 | $17,000 |
| 2022 | 14 | 648 | 771 | $92,673 | $31,972 |
| 2021 | 19 | 696 | 859 | $48,850 | $20,948 |
| 2020 | 18 | 657 | 800 | $46,274 | $17,620 |
Total Patients
2,312
Total Services
2,838
Medicare Billing
$87,540
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 120 | $29,160 | $6,955 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 125 | $21,500 | $5,254 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $5,208 | $2,132 | 40.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,770 | $1,955 | 41.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 61 | $610.00 | $512.40 | 84.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 53 | $424.00 | $112.20 | 26.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 13 | $169.00 | $79.43 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 158 | $34,238 | $10,243 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $16,097 | $7,251 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 139 | $20,828 | $6,757 | 32.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 31 | 31 | $9,990 | $4,187 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,976 | $1,190 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 104 | 156 | $1,806 | $458.54 | 25.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $975.00 | $416.88 | 42.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $584.00 | $351.89 | 60.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 15 | 15 | $705.00 | $252.00 | 35.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 19 | 19 | $550.00 | $225.30 | 41.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 70 | 85 | $639.00 | $188.76 | 29.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 17 | 17 | $578.00 | $179.52 | 31.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 25 | 25 | $332.00 | $153.47 | 46.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 15 | 15 | $375.00 | $116.55 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 151 | $17,674 | $7,069 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 87 | $13,470 | $5,534 | 41.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 35 | 38 | $4,332 | $1,845 | 42.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 62 | 86 | $1,649 | $908.16 | 55.1% |
About Patrick Richardson
Patrick Richardson is a Family healthcare provider based in Lawrenceburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1265984785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Richardson has received a total of $436.19 in payments from pharmaceutical and medical device companies, with $105.21 received in 2024. These payments were reported across 29 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($436.19).
As a Medicare-enrolled provider, Richardson has provided services to 2,312 Medicare beneficiaries, totaling 2,838 services with total Medicare billing of $87,540. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Lawrenceburg, KY
- Active Since 11/01/2016
- Last Updated 11/01/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1265984785
Products in Payments
- VRAYLAR (Drug) $63.44
- XIFAXAN (Drug) $61.11
- EMGALITY (Drug) $53.07
- Ozempic (Drug) $51.82
- Rybelsus (Drug) $33.71
- Korlym (Drug) $29.60
- UBRELVY (Drug) $29.33
- MYCAPSSA (Drug) $19.23
- QUVIVIQ (Drug) $14.78
- JARDIANCE (Drug) $14.36
- SKYCLARYS (Drug) $13.98
- QULIPTA (Drug) $12.32
- FreeStyle Libre (Device) $11.66
- ENTRESTO (Drug) $11.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lawrenceburg
Erika Crowell, F-Np, F-NP
Family — Payments: $12,449
Family $12,449
Kimberly Phillips, Aprn, APRN
Family — Payments: $9,424
Family $9,424
Angela Buck, Aprn, APRN
Family — Payments: $4,372
Family $4,372
Haley Phillips, Fnp-C, FNP-C
Family — Payments: $3,545
Family $3,545
Ashley Boles, Aprn, APRN
Family — Payments: $3,027
Family $3,027
Heather Watkins, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $2,973
Family $2,973